[3] The British Society for Haematology guidelines emphasise that the response to treatment should be monitored through clinical assessment and blood count testing, rather than routine measurement of B12 levels after treatment has started
The best choice depends on the cause of deficiency, absorption issues, and your clinicians recommendation
The aim is not only to correct B12 levels, but also to prevent the problem from returning
Unlike some other peptides that target one system of the body, BPC-157 seems to have widespread benefits on multiple tissuesincluding muscle, tendons, ligaments, the gut, and even the nervous system
Further studies are needed to confirm the lower B12 levels in relation to obesity or semaglutide use, and their effect when combined with GLP-1 drugs